focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,350.00
Bid: 12,346.00
Ask: 12,350.00
Change: -14.00 (-0.11%)
Spread: 4.00 (0.032%)
Open: 12,358.00
High: 12,376.00
Low: 12,276.00
Prev. Close: 12,364.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK sends first of 100 million promised vaccine doses to poorer nations

Wed, 28th Jul 2021 16:35

(Alliance News) - The first batch of excess coronavirus vaccines from Britain will be shipped off to "vulnerable" nations and Commonwealth allies this week, the UK Foreign Secretary has announced.

Leaders of the major industrialised nations at the G7 summit in Cornwall pledged more than one billion doses of Covid-19 vaccine – 870 million jabs shared directly and the rest through funding to the Covax initiative – to poorer countries.

Prime Minister Boris Johnson confirmed the UK's contribution to the one billion dose pledge is another 100 million vaccines from now to next June, with Dominic Raab announcing on Wednesday that the first shipment of nine million spare Oxford-AstraZeneca PLC will be made this week.

And in a message to western countries who have unused stockpiles of AstraZeneca jabs, Raab stressed that bodies ranging from the World Health Organisation to the European Medicines Agency had approved the British-designed vaccine as safe, arguing it was "crucially important" for all nations to vaccinate their populations.

It comes as parts of Australia have been forced to go back into lockdown despite the UK ally having three million unboxed doses of the AstraZeneca inoculation stored, according to reports.

Fears about the Oxford jab's side effects, including an increased risk of blood clots, have seen it shunned in some wealthy countries.

The Foreign Secretary visited an AstraZeneca manufacturing site in Oxford on Wednesday to announce that the first despatch of excess UK doses will be making their way to poorer nations this week – with five million to be distributed via the WHO's Covax scheme and another four million bilaterally.

Speaking to the PA news agency after the visit, the Cabinet minister said: "We succeeded in double-vaccinating 70% of the adult population, the UK economy is bouncing back but we know we're not going to be safe in the UK until everyone is safe.

"That is why we have been leading the (international) vaccine rollout to give enough doses to get the world vaccinated by the middle of next year, rather than the current trajectory, which is the end of 2024."

Raab said the UK was delivering on its G7 pledge of sending 100 million surplus vaccines to the "poorest and most vulnerable countries around the world" before the middle of 2022.

"The first nine million doses will be going on Friday to countries from vulnerable countries in the Indo-Pacific, such as Laos, Cambodia, key partners like Indonesia, right the way through the Commonwealth countries from Kenya to Jamaica," the Cabinet minister added.

"I think what it shows, as well as the domestic rollout and the importance of coming out of the lockdowns in the UK, is that global Britain is also a lifesaving force for good in the world."

Indonesia will receive 600,000 doses of those being handed out bilaterally, 300,000 will be sent to Jamaica and 817,000 are to be transported to Kenya, among other countries, the Foreign Office said.

Raab, who is also First Secretary of State, joined the prime minister and fellow Cabinet colleague Therese Coffey in refusing to repeat Michael Gove's assertion that it was "selfish" to refuse a vaccine.

The Chancellor of the Duchy of Lancaster's comment comes as the government prepares to make being double-jabbed a condition of entry to nightclubs in September in a bid to increase the number of young people coming forward for inoculation.

Asked what he made of Gove's remark, Raab told PA: "Look, I think people should get vaccinated for their own self-interest because it is far safer to do so, and I would encourage everyone to do so."

Professor Sir John Bell said the UK's decision to send unneeded Covid-19 vaccines to developing nations was "long overdue" and would help guard against new variants of the virus forming.

The Regius Professor of Medicine at Oxford University told BBC Radio 4's World At One programme: "I think it is a bit self-indulgent, to be honest, of western countries fretting about these kinds of issues (what rights to afford the fully vaccinated) when the vast majority of the globe remains completely unvaccinated, with massive levels of viral replication sweeping through the population.

"If you want variants, you've got the perfect storm for that, and it is not in Watford – it is in Zimbabwe and Rwanda and South Africa."

By Patrick Daly, PA Political Correspondent

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
20 May 2024 08:24

TOP NEWS: AstraZeneca plans to build manufacturing plant in Singapore

(Alliance News) - AstraZeneca PLC on Monday announced plans for a USD1.5 billion manufacturing facility in Singapore to produce antibody drug conjugates, treatments that deliver "highly potent cancer-killing agents".

Read more
20 May 2024 07:47

LONDON BRIEFING: Keywords would back GBP2.0 billion bid as EQT circles

(Alliance News) - London's FTSE 100 is called to open higher at the start of the week, while the pound climbed and gold hit another record high, with investors hopeful the Federal Reserve could soon cut US interest rates.

Read more
20 May 2024 07:22

AstraZeneca announces $1.5bn Singapore manufacturing facility

(Sharecast News) - AstraZeneca announced plans to construct a $1.5bn manufacturing facility in Singapore on Monday, dedicated to the production of antibody drug conjugates (ADCs).

Read more
17 May 2024 22:25

Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial

May 17 (Reuters) - AstraZeneca owes Pfizer $107.5 million in damages, a Delaware federal jury said on Friday after finding that AstraZeneca's blockbuster lung cancer drug Tagrisso violated its Wyeth unit's patent rights.

Read more
16 May 2024 10:27

AstraZeneca trials yield positive results for immunocompromised patients

(Alliance News) - AstraZeneca PLC on Thursday said results from recent trials revealed a significant reduction in cases of Covid-19.

Read more
12 May 2024 13:25

Pfizer and AstraZeneca announce new investments of nearly $1 billion in France

PARIS, May 12 (Reuters) - Leading healthcare companies Pfizer and AstraZeneca announced on Sunday new investments in France worth a total of nearly $1 billion, ahead of the start of this year's annual 'Choose France' business summit.

Read more
8 May 2024 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
8 May 2024 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
8 May 2024 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
8 May 2024 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.